Edwards Lifesciences Overview
- Founded
-
1958

- Status
-
Public
- Employees
-
15,700

- Stock Symbol
-
EW

- Investments
-
37
- Share Price
-
$78.14
- (As of Friday Closing)
Edwards Lifesciences General Information
Description
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.
Contact Information
- One Edwards Way
- Irvine, CA 92614
- United States
Edwards Lifesciences Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$78.14 | $78.21 | $67.13 - $131.10 | $48.4B | 618M | 5.11M | $2.35 |
Edwards Lifesciences Financials Summary
In Thousands, USD |
TTM 30-Sep-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
---|---|---|---|---|
EV | 50,392,896 | 79,771,934 | 56,253,740 | 47,971,099 |
Revenue | 5,363,800 | 5,232,500 | 4,386,300 | 4,348,000 |
EBITDA | 1,812,700 | 1,837,800 | 1,016,300 | 1,244,300 |
Net Income | 1,458,800 | 1,503,100 | 823,400 | 1,046,900 |
Total Assets | 8,638,200 | 8,502,600 | 7,237,100 | 6,488,100 |
Total Debt | 686,800 | 690,300 | 694,900 | 678,800 |
Edwards Lifesciences Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Edwards Lifesciences Comparisons
Industry
Financing
Details
Edwards Lifesciences Competitors (43)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Integra Lifesciences Holdings | Corporation | Princeton, NJ | 0000 | 00000 | 000000 - 000 | 00000 |
0000000 | Formerly VC-backed | Kalamazoo, MI | 00000 | 00000000 | ||
00000000 | Formerly VC-backed | San Diego, CA | 0000 | 00000 | 000000 - 000 | 00000 |
00000000 | Formerly VC-backed | London, United Kingdom | 0000 | 000.00 | 000000000000 | |
000000 0000000000 | Corporation | Marlborough, MA | 00000 | 00000 | 000000&0 |
Edwards Lifesciences Patents
Edwards Lifesciences Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
DE-102022118354-A1 | Heart valve repair devices and delivery devices therefor | Pending | 23-Jul-2021 | 000000000 | |
DE-102022116343-A1 | Heart valve repair devices and delivery devices therefor | Pending | 01-Jul-2021 | 000000000 | 00 |
US-20220249232-A1 | Implanting grafts to valve leaflets for cardiac procedures | Pending | 10-Feb-2021 | 0000000000 | |
US-20220241564-A1 | Pulmonary vein shunting | Pending | 01-Feb-2021 | 0000000000 | |
US-20220211500-A1 | Tissue remodeling system and methods | Pending | 05-Jan-2021 | A61F2/2454 |
Edwards Lifesciences Executive Team (39)
Edwards Lifesciences Board Members (15)
Name | Representing | Role | Since |
---|---|---|---|
000000 00000000 | Self | Board Member | 000 0000 |
000000 00000 | Self | Board Member | 000 0000 |
000000 00000 | Self | Board Member | 000 0000 |
0000000 000000000 | Edwards Lifesciences | Chief Executive Officer & Chairman | 000 0000 |
00000000 000000000 | Self | Board Member | 000 0000 |
Edwards Lifesciences Signals
Edwards Lifesciences Investments & Acquisitions (37)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0-0000 | 22-Sep-2020 | 00000 0000 | 0000 | Therapeutic Devices | |
0000000 00000 | 15-Jul-2020 | 00000 0000 | 0000 | Decision/Risk Analysis | |
0000000 00000 | 28-Apr-2020 | 00000 0000 | Decision/Risk Analysis | ||
0000-00000 00 | 18-Apr-2019 | 0000000000 | 00000 | Monitoring Equipment | 000000000 |
Mitralign | 12-Mar-2019 | Merger/Acquisition | Surgical Devices |
Edwards Lifesciences Subsidiaries (2)
Company Name | Industry | Location | Founded |
---|---|---|---|
Valtech Cardio | Therapeutic Devices | Or Yehuda, Israel | 2005 |
0000000 0000000000 | Corporate Pension | Irvine, CA | 0000 |
Edwards Lifesciences ESG
Risk Overview
Risk Rating
Updated November, 29, 2022
19.33 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,613
Rank
Percentile

Healthcare
Industry
00 of 635
Rank
Percentile

Medical Devices
Subindustry
0. of 228
Rank
Percentile

Edwards Lifesciences Exits (13)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
00000000000 | 01-Feb-2017 | 00000 00000 00 | 0000 | Completed |
|
0000000000000 | 08-Dec-2014 | 00000 00000 00 | 0000 | Completed |
|
000000 0000 000000 | 26-Jun-2013 | 00000 00000 00 | 000.00 | Completed |
|
0000000000000 | 22-Feb-2013 | 00000 00000 00 | 0000 | Completed |
|
Sphere Medical Holding | 12-Apr-2010 | Later Stage VC | 00.00 | Completed |
|